Combining Chinese medicine and nutrition to improve weight loss after bariatric surgery
Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery
This study is testing if a combination of Chinese herbal medicine and special meal replacements can help people who have had weight loss surgery feel better and lose more weight.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06419764 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Chinese herbal granule preparations on gastrointestinal symptoms in patients who have undergone bariatric surgery. It aims to establish a treatment model that integrates traditional Chinese medicine with bariatric surgery, providing additional evidence-based support for clinical practice. The intervention includes a Spleen Invigorating and Weight Reducing Decoction along with dietary meal replacements. The study focuses on patients with specific Traditional Chinese Medicine syndrome classifications.
Who should consider this trial
Good fit: Ideal candidates are individuals with a BMI of 27.5 kg/m² or higher who are undergoing metabolic bariatric surgery and have a specific Traditional Chinese Medicine syndrome classification.
Not a fit: Patients with contraindications for bariatric surgery, type 1 diabetes, or significant systemic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance weight loss and improve recovery for patients after bariatric surgery.
How similar studies have performed: While the integration of traditional Chinese medicine with modern surgical practices is innovative, similar studies have shown promise in enhancing recovery and outcomes in various medical fields.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. BMI ≥ 27.5 kg/m²; 2. Undergoing metabolic bariatric surgery; 3. Traditional Chinese Medicine syndrome differentiation classified as Spleen Deficiency and Excess Dampness syndrome. Exclusion Criteria: 1. Contraindications for metabolic bariatric surgery; 2. Type 1 diabetes; 3. Complicated by other significant systemic diseases, such as severe liver and kidney diseases, malignant tumors, psychiatric disorders, etc; 4. Concurrent use of other medications or treatments that may affect body weight, such as metformin, semaglutide, endoscopic interventions, etc; 5. Pregnant or lactating women.
Where this trial is running
Beijing
- China-Japan Friendship Hospital — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Huang Yishan, doctor
- Email: bucmyishan@163.com
- Phone: 18810621201
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.